$PFE Company News Ken Fisher's new top stock picks 2:48

New Post Public Reply Private Reply Replies (0) Message Board

Jan 22, 2014 at 4:44 PM

$PFE Company News

Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Audit: Medicare overpays for penis pumps 6:48 p.m. Jan. 14, 2014 - blogs.marketwatch.com
A contrarian take on the market’s correction 12:48 p.m. Jan. 9, 2014 - Mark Hulbert
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Dairy company Emmi acquires 50% stake in Mexideli 5:36 a.m. Jan. 3, 2014 - MarketWatch.com
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease 2:00 p.m. Today - Seeking Alpha
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 6:31 a.m. Today - benzinga.com
Facebook Cements Position Among Most Traded Stocks 6:08 a.m. Today - 247WallSt.com
Pfizer Finds Success With Chantix Clinical Study 7:44 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Is Johnson & Johnson Enticing After Recent Headlines? 5:02 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants? 11:14 a.m. Jan. 21, 2014 - 247WallSt.com
Pfizer treatment to stop smoking meets endpoints 10:58 a.m. Jan. 21, 2014 - Seeking Alpha
Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 9:05 a.m. Jan. 21, 2014 - TheStreet.com
ViiV Healthcare's Tivicay Approved in Europe 5:55 a.m. Jan. 21, 2014 - benzinga.com
J&J Needs to Earn Investor Loyalty 1:30 p.m. Jan. 20, 2014 - WSJ.com
Sometimes Leasing a Stock Is Better Than Buying 1:31 p.m. Jan. 17, 2014 - TheStreet.com
Niche REITs Look Cheap 8:02 a.m. Jan. 17, 2014 - Barrons.com
J&J Continues ‘Strategic Pruning’ With This Divestiture 4:08 p.m. Jan. 16, 2014 - Wall St. Cheat Sheet
AstraZeneca: Should You Buy This 4.5% Yielder? 11:56 a.m. Jan. 16, 2014 - Seeking Alpha
Drug Buyouts On The Rise -- But Buyers Changing 5:42 p.m. Jan. 15, 2014 - Investors Business Daily
Can GlaxoSmithKline Break Higher? 5:29 p.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Chevron? Dividend Growth Plus Promising Projects 3:41 p.m. Jan. 15, 2014 - Seeking Alpha
Strategy Update from Merck - Analyst Blog 3:41 p.m. Jan. 15, 2014 - Zacks.com
Where to Find Yield 10:20 a.m. Jan. 15, 2014 - Barrons.com
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. Jan. 14, 2014 - TheStreet.com

Pharmerging Markets 2012-2016 11:12 a.m. Today - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Today - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Today - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth 8:00 a.m. Dec. 20, 2013 - PR Newswire
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

3700 Midway Seals $32.5M Deal for Midland Apartments

A New Landmark in Midland Midland, Texas just got itself a fresh, shiny addition in the form of a real estate deal worth $32.5 million. On the books as of September 1, 2026, 3700 Midway, LLC has grabbed hold of Midway Station, setting their stakes straight in the heart of Midland's bustling business corridor. The Scope of the Deal This acquisition is more than just a line...

Union Savings Bank Leverages AI for Strategic Growth

USB's Data-Driven Approach Transforms Banking Remember the days of handing out toasters to keep customers? Union Savings Bank (USB) sure doesn't seem to, as it embraces tech-savvy methods to keep its clientele content. Instead, the $3.3 billion community bank based in Danbury, Connecticut, has deployed NGDATA's AI Hub, transforming its approach to reducing customer churn...

Innventure Faces Class Action Over Alleged Deception

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Qingdao-Yerevan Collaboration: New Strategic Heights

Qingdao and Yerevan: More Than Just a Port of Call Who would have thought? An Armenian ambassador talking shop in a Chinese port city isn't your everyday headline, but let me tell you, it's big news if you're watching global growth. Armenian Ambassador Vahe Gevorgyan's recent spiel in Qingdao might not turn heads on Wall Street, but there's more under the hood than meets...

Manulife's $750M US Offering: Risky or Strategic?

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Palmer's Design Fuels Child Cancer Awareness Drive

Imagine a cancer struggle fueling creativity – a hopeful story from the racetrack lights up this reality as Valvoline and a young survivor rev up their engines for children with blood cancer. Powerful Partnership Takes Unforgettable Turn Palmer Goforth, a twelve-year-old cancer survivor, never imagined his hobby of drawing sketches would lead to designing a NASCAR car....

ADA Audit Reveals Gaps in Event Management at 2026 Session

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

California's Annual Recovery Happens Event Unites Community

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

ZPMC Names Two New 38,000 DWT Vessels for Chipolbrok

Navigating Uncharted Waters with New Vessels Some days, you see a giant leap in an industry and think, "Well, someone's got ambition." Here, we're talking about ZPMC's gutsy naming ceremony for two spanking new 38,000 DWT multipurpose heavy-lift ships destined for Chipolbrok, happening fresh off the docks in Shanghai. Specifications That Make Waves Imagine a vessel the...

Aitan Raises $41M to Expand Robotic Warfare Tech

Pioneering Sovereign Robotic Warfare The defense sector's landscape is shifting, and Aitan is driving a movement with their 'Robotic Sovereignty-as-a-Service'. Coming out of stealth with a hefty $41 million funding boost, this Israeli-American company is redefining modern warfare's playbook. In today's unpredictable world, traditional combat methods are becoming relics of...